| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mosaicism | 2 | 2004 | 21 | 0.380 |
Why?
|
| Trisomy | 2 | 2004 | 47 | 0.380 |
Why?
|
| Lung | 13 | 2017 | 849 | 0.380 |
Why?
|
| Embolism, Amniotic Fluid | 2 | 2012 | 3 | 0.350 |
Why?
|
| Brachial Artery | 1 | 2008 | 34 | 0.320 |
Why?
|
| Neuroleptic Malignant Syndrome | 1 | 2007 | 12 | 0.290 |
Why?
|
| Reoviridae Infections | 6 | 2003 | 10 | 0.270 |
Why?
|
| Extraembryonic Membranes | 1 | 2004 | 10 | 0.250 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2004 | 28 | 0.250 |
Why?
|
| Wilms Tumor | 1 | 2004 | 47 | 0.250 |
Why?
|
| Lung Diseases | 3 | 2017 | 175 | 0.240 |
Why?
|
| Calcinosis | 2 | 2005 | 241 | 0.230 |
Why?
|
| Kidney Neoplasms | 1 | 2004 | 206 | 0.220 |
Why?
|
| Blood Pressure | 2 | 2008 | 1451 | 0.220 |
Why?
|
| Orthoreovirus, Mammalian | 4 | 2003 | 7 | 0.220 |
Why?
|
| Cardiovascular Diseases | 1 | 2008 | 940 | 0.190 |
Why?
|
| Abnormalities, Multiple | 2 | 2004 | 109 | 0.190 |
Why?
|
| Hypertension | 2 | 2008 | 1535 | 0.170 |
Why?
|
| Scleroderma, Systemic | 5 | 2013 | 446 | 0.170 |
Why?
|
| In Situ Hybridization | 3 | 1999 | 201 | 0.150 |
Why?
|
| Cryptogenic Organizing Pneumonia | 3 | 2003 | 5 | 0.150 |
Why?
|
| Adult | 16 | 2017 | 21403 | 0.150 |
Why?
|
| Pleura | 5 | 1995 | 25 | 0.150 |
Why?
|
| Fibroblasts | 3 | 2008 | 902 | 0.140 |
Why?
|
| Adenovirus Infections, Human | 1 | 1996 | 4 | 0.140 |
Why?
|
| Female | 26 | 2017 | 38074 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1996 | 23 | 0.140 |
Why?
|
| Herpes Simplex | 1 | 1996 | 35 | 0.140 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 1996 | 92 | 0.130 |
Why?
|
| Fatal Outcome | 3 | 2004 | 164 | 0.130 |
Why?
|
| Pregnancy | 4 | 2012 | 2334 | 0.120 |
Why?
|
| Pulmonary Fibrosis | 4 | 2004 | 157 | 0.120 |
Why?
|
| Humans | 34 | 2017 | 68618 | 0.120 |
Why?
|
| Military Personnel | 1 | 2017 | 221 | 0.120 |
Why?
|
| Thrombin | 2 | 2004 | 117 | 0.110 |
Why?
|
| Hypertension, Pulmonary | 2 | 2013 | 232 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 1996 | 154 | 0.110 |
Why?
|
| GATA6 Transcription Factor | 1 | 2013 | 27 | 0.110 |
Why?
|
| Pleurisy | 2 | 1989 | 8 | 0.100 |
Why?
|
| Indium | 1 | 2011 | 2 | 0.100 |
Why?
|
| Infant, Newborn | 4 | 2012 | 2455 | 0.100 |
Why?
|
| Pregnancy Trimester, Third | 2 | 2005 | 39 | 0.100 |
Why?
|
| Occupational Diseases | 1 | 2011 | 68 | 0.100 |
Why?
|
| Autopsy | 2 | 2005 | 56 | 0.100 |
Why?
|
| Endothelium, Vascular | 1 | 2013 | 371 | 0.090 |
Why?
|
| Occupational Exposure | 1 | 2011 | 122 | 0.090 |
Why?
|
| Disease Models, Animal | 8 | 2008 | 2550 | 0.090 |
Why?
|
| Fibrosis | 9 | 2008 | 371 | 0.090 |
Why?
|
| Male | 18 | 2017 | 37321 | 0.090 |
Why?
|
| T-Lymphocytes | 3 | 2003 | 597 | 0.090 |
Why?
|
| Diagnosis, Differential | 3 | 2012 | 1140 | 0.090 |
Why?
|
| Prevalence | 2 | 2017 | 1619 | 0.080 |
Why?
|
| RNA, Messenger | 6 | 2013 | 1664 | 0.080 |
Why?
|
| Actins | 3 | 2008 | 249 | 0.070 |
Why?
|
| Muscle Rigidity | 1 | 2007 | 4 | 0.070 |
Why?
|
| Hypovolemia | 1 | 2007 | 7 | 0.070 |
Why?
|
| Dehydration | 1 | 2007 | 15 | 0.070 |
Why?
|
| Verapamil | 1 | 2007 | 30 | 0.070 |
Why?
|
| Kallikreins | 2 | 1999 | 323 | 0.070 |
Why?
|
| Tremor | 1 | 2007 | 16 | 0.070 |
Why?
|
| Caveolin 1 | 1 | 2008 | 59 | 0.070 |
Why?
|
| Forensic Medicine | 1 | 2007 | 26 | 0.070 |
Why?
|
| Creatine Kinase | 1 | 2007 | 46 | 0.070 |
Why?
|
| Middle Aged | 11 | 2017 | 21147 | 0.070 |
Why?
|
| Nutrition Surveys | 1 | 2008 | 208 | 0.070 |
Why?
|
| Serpins | 2 | 1999 | 205 | 0.070 |
Why?
|
| Liver Failure, Acute | 1 | 2007 | 49 | 0.070 |
Why?
|
| Skin | 5 | 1996 | 451 | 0.070 |
Why?
|
| Psychotropic Drugs | 1 | 2007 | 83 | 0.070 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2008 | 110 | 0.070 |
Why?
|
| Calcium Channel Blockers | 1 | 2007 | 138 | 0.070 |
Why?
|
| Fever | 1 | 2007 | 96 | 0.070 |
Why?
|
| Risk Factors | 3 | 2017 | 5731 | 0.070 |
Why?
|
| Regression Analysis | 1 | 2008 | 737 | 0.070 |
Why?
|
| Reoviridae | 2 | 1996 | 14 | 0.070 |
Why?
|
| Protein Kinase C | 2 | 2004 | 270 | 0.070 |
Why?
|
| Immunohistochemistry | 7 | 2008 | 1174 | 0.070 |
Why?
|
| Silicones | 2 | 1996 | 32 | 0.070 |
Why?
|
| Breast Implants | 2 | 1996 | 18 | 0.070 |
Why?
|
| Animals | 20 | 2013 | 20881 | 0.070 |
Why?
|
| Mice | 13 | 2013 | 8474 | 0.070 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2005 | 40 | 0.060 |
Why?
|
| Carrier Proteins | 2 | 1999 | 597 | 0.060 |
Why?
|
| Anticonvulsants | 1 | 2007 | 223 | 0.060 |
Why?
|
| Carcinoid Tumor | 1 | 2005 | 20 | 0.060 |
Why?
|
| Mammaplasty | 2 | 1996 | 41 | 0.060 |
Why?
|
| Methylprednisolone | 2 | 2003 | 99 | 0.060 |
Why?
|
| Chromosome Banding | 1 | 2004 | 24 | 0.060 |
Why?
|
| Mice, Inbred CBA | 5 | 2003 | 107 | 0.060 |
Why?
|
| Models, Statistical | 1 | 2008 | 448 | 0.060 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2005 | 116 | 0.060 |
Why?
|
| Pulmonary Circulation | 1 | 2004 | 79 | 0.060 |
Why?
|
| Dyspnea | 1 | 2005 | 87 | 0.060 |
Why?
|
| Acute Kidney Injury | 1 | 2007 | 232 | 0.060 |
Why?
|
| Glucocorticoids | 2 | 2003 | 222 | 0.060 |
Why?
|
| Age Factors | 1 | 2008 | 1864 | 0.060 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2005 | 201 | 0.060 |
Why?
|
| Heart Transplantation | 1 | 2006 | 328 | 0.060 |
Why?
|
| Catheter Ablation | 1 | 2005 | 229 | 0.060 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2004 | 144 | 0.060 |
Why?
|
| Lung Neoplasms | 2 | 2005 | 1173 | 0.050 |
Why?
|
| Young Adult | 2 | 2017 | 5717 | 0.050 |
Why?
|
| Bronchoalveolar Lavage Fluid | 5 | 2003 | 117 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2008 | 694 | 0.050 |
Why?
|
| Muscle Contraction | 1 | 2003 | 210 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2005 | 475 | 0.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2005 | 300 | 0.050 |
Why?
|
| Macrophages | 3 | 1995 | 647 | 0.050 |
Why?
|
| DNA | 1 | 2004 | 597 | 0.050 |
Why?
|
| Adolescent | 3 | 2017 | 8912 | 0.050 |
Why?
|
| Heart | 1 | 2006 | 850 | 0.050 |
Why?
|
| United States | 2 | 2017 | 7367 | 0.050 |
Why?
|
| Obesity | 1 | 2008 | 1076 | 0.050 |
Why?
|
| Biopsy | 2 | 2017 | 540 | 0.050 |
Why?
|
| Rabbits | 6 | 2005 | 509 | 0.050 |
Why?
|
| Connective Tissue | 3 | 1996 | 61 | 0.040 |
Why?
|
| Myocardial Infarction | 1 | 2005 | 807 | 0.040 |
Why?
|
| Smoking | 1 | 2008 | 1452 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2005 | 629 | 0.040 |
Why?
|
| Empyema | 2 | 1989 | 6 | 0.040 |
Why?
|
| Respiratory Tract Infections | 2 | 2002 | 91 | 0.040 |
Why?
|
| Ethanol | 1 | 2005 | 893 | 0.040 |
Why?
|
| Disease Progression | 2 | 2013 | 1038 | 0.040 |
Why?
|
| Salivary Glands | 1 | 1998 | 52 | 0.040 |
Why?
|
| Pleural Effusion | 2 | 1989 | 74 | 0.040 |
Why?
|
| Blood Vessels | 1 | 1999 | 102 | 0.040 |
Why?
|
| Heart Failure | 1 | 2006 | 1180 | 0.040 |
Why?
|
| Orthoreovirus | 1 | 1997 | 1 | 0.040 |
Why?
|
| Granuloma, Respiratory Tract | 1 | 2017 | 2 | 0.040 |
Why?
|
| Idiopathic Interstitial Pneumonias | 1 | 2017 | 2 | 0.040 |
Why?
|
| Middle East | 1 | 2017 | 17 | 0.040 |
Why?
|
| Pancreas | 1 | 1998 | 225 | 0.040 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2017 | 15 | 0.040 |
Why?
|
| Pleural Neoplasms | 1 | 1997 | 7 | 0.040 |
Why?
|
| Pulmonary Blastoma | 1 | 1997 | 7 | 0.040 |
Why?
|
| Mast Cells | 2 | 1995 | 113 | 0.030 |
Why?
|
| Brain | 1 | 2007 | 2176 | 0.030 |
Why?
|
| Acyclovir | 1 | 1996 | 38 | 0.030 |
Why?
|
| Receptors, Bradykinin | 1 | 1996 | 50 | 0.030 |
Why?
|
| Endothelial Cells | 2 | 2013 | 384 | 0.030 |
Why?
|
| Kininogens | 1 | 1996 | 88 | 0.030 |
Why?
|
| Cicatrix | 1 | 1996 | 60 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 546 | 0.030 |
Why?
|
| Talc | 1 | 1995 | 3 | 0.030 |
Why?
|
| Pleurodesis | 1 | 1995 | 11 | 0.030 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1996 | 126 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2008 | 175 | 0.030 |
Why?
|
| Splenosis | 1 | 1995 | 4 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 880 | 0.030 |
Why?
|
| Dermatologic Surgical Procedures | 2 | 1996 | 12 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 1996 | 397 | 0.030 |
Why?
|
| Cytokines | 3 | 2003 | 866 | 0.030 |
Why?
|
| Eosinophilia-Myalgia Syndrome | 1 | 1994 | 24 | 0.030 |
Why?
|
| Carrageenan | 2 | 1993 | 7 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 1046 | 0.030 |
Why?
|
| Family | 1 | 1996 | 293 | 0.030 |
Why?
|
| Protein Kinase C-epsilon | 2 | 2004 | 28 | 0.030 |
Why?
|
| Tetracycline | 2 | 1993 | 29 | 0.030 |
Why?
|
| Tryptophan | 1 | 1994 | 65 | 0.030 |
Why?
|
| Cardiac Catheterization | 2 | 2006 | 419 | 0.030 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2013 | 7 | 0.030 |
Why?
|
| Streptokinase | 1 | 1993 | 23 | 0.030 |
Why?
|
| Familial Primary Pulmonary Hypertension | 1 | 2013 | 25 | 0.030 |
Why?
|
| Empyema, Pleural | 1 | 1993 | 13 | 0.030 |
Why?
|
| Logistic Models | 1 | 2017 | 1420 | 0.030 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 2013 | 21 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 1465 | 0.030 |
Why?
|
| Mice, Inbred Strains | 2 | 2008 | 181 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 58 | 0.030 |
Why?
|
| Chemokines | 2 | 2003 | 119 | 0.030 |
Why?
|
| Pancreatitis-Associated Proteins | 1 | 2011 | 3 | 0.030 |
Why?
|
| Blood Substitutes | 1 | 2012 | 8 | 0.030 |
Why?
|
| Pneumonia | 1 | 2013 | 110 | 0.030 |
Why?
|
| Blood Coagulation Tests | 1 | 2012 | 31 | 0.030 |
Why?
|
| Hypoxia | 1 | 2013 | 169 | 0.030 |
Why?
|
| Apgar Score | 1 | 2012 | 22 | 0.030 |
Why?
|
| Survival | 1 | 2012 | 22 | 0.030 |
Why?
|
| Collagen | 2 | 2008 | 636 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2013 | 189 | 0.030 |
Why?
|
| Analgesia, Obstetrical | 1 | 2012 | 15 | 0.020 |
Why?
|
| Plasma | 1 | 2012 | 58 | 0.020 |
Why?
|
| Shock | 1 | 2012 | 28 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2011 | 123 | 0.020 |
Why?
|
| Erythrocyte Transfusion | 1 | 2012 | 72 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2013 | 447 | 0.020 |
Why?
|
| Resuscitation | 1 | 2012 | 77 | 0.020 |
Why?
|
| Microscopy, Electron | 3 | 1997 | 351 | 0.020 |
Why?
|
| Blood Loss, Surgical | 1 | 2012 | 79 | 0.020 |
Why?
|
| Kidney | 1 | 1996 | 945 | 0.020 |
Why?
|
| Cesarean Section | 1 | 2012 | 101 | 0.020 |
Why?
|
| Aged | 5 | 2006 | 14862 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2008 | 2673 | 0.020 |
Why?
|
| Acute Disease | 3 | 2002 | 658 | 0.020 |
Why?
|
| Bronchoscopy | 1 | 2011 | 147 | 0.020 |
Why?
|
| Ketotifen | 1 | 1990 | 1 | 0.020 |
Why?
|
| Lymphocyte Transfusion | 1 | 1989 | 4 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 1989 | 24 | 0.020 |
Why?
|
| Ethchlorvynol | 1 | 1989 | 1 | 0.020 |
Why?
|
| Fasciotomy | 1 | 1989 | 12 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2012 | 453 | 0.020 |
Why?
|
| Leg Injuries | 1 | 1989 | 18 | 0.020 |
Why?
|
| Seizures | 1 | 2012 | 279 | 0.020 |
Why?
|
| Apoptosis | 2 | 2008 | 1641 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2002 | 507 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 1989 | 149 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2013 | 1553 | 0.020 |
Why?
|
| Parasitic Diseases | 1 | 1988 | 9 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2012 | 705 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2013 | 1692 | 0.020 |
Why?
|
| Virus Diseases | 1 | 1988 | 31 | 0.020 |
Why?
|
| Pulmonary Artery | 2 | 2006 | 323 | 0.020 |
Why?
|
| Surgical Flaps | 1 | 1989 | 120 | 0.020 |
Why?
|
| Leg | 1 | 1989 | 191 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2013 | 1330 | 0.020 |
Why?
|
| Mycoses | 1 | 1988 | 60 | 0.020 |
Why?
|
| Skin Diseases | 1 | 1989 | 122 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2013 | 2083 | 0.020 |
Why?
|
| Tenascin | 1 | 2008 | 39 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2008 | 34 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 2 | 2004 | 183 | 0.020 |
Why?
|
| Forensic Toxicology | 1 | 2007 | 3 | 0.020 |
Why?
|
| Accidents | 1 | 2007 | 20 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 1293 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 1988 | 163 | 0.020 |
Why?
|
| Hypercholesterolemia | 1 | 2007 | 86 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2017 | 7277 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2008 | 765 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2008 | 247 | 0.020 |
Why?
|
| Drug Overdose | 1 | 2007 | 67 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2007 | 304 | 0.020 |
Why?
|
| Indoles | 1 | 2007 | 146 | 0.020 |
Why?
|
| Biomarkers | 1 | 2011 | 1593 | 0.020 |
Why?
|
| Electron Probe Microanalysis | 2 | 1996 | 16 | 0.020 |
Why?
|
| Coronary Thrombosis | 1 | 2005 | 45 | 0.020 |
Why?
|
| Heart Septum | 1 | 2005 | 84 | 0.020 |
Why?
|
| Virus Replication | 2 | 1996 | 104 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2008 | 483 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 2005 | 98 | 0.020 |
Why?
|
| Bronchi | 1 | 2005 | 59 | 0.020 |
Why?
|
| Rats | 1 | 2013 | 5300 | 0.020 |
Why?
|
| Protein Kinase C-alpha | 1 | 2004 | 24 | 0.020 |
Why?
|
| Receptor, PAR-1 | 1 | 2004 | 30 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2004 | 37 | 0.020 |
Why?
|
| Microcirculation | 1 | 2004 | 77 | 0.020 |
Why?
|
| Fas Ligand Protein | 1 | 2004 | 64 | 0.020 |
Why?
|
| Mitral Valve | 1 | 2005 | 166 | 0.020 |
Why?
|
| Pulmonary Alveoli | 1 | 2004 | 62 | 0.020 |
Why?
|
| Myocardial Ischemia | 1 | 2005 | 172 | 0.010 |
Why?
|
| Heart Rate | 1 | 2006 | 568 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2004 | 97 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 2007 | 365 | 0.010 |
Why?
|
| HIV Infections | 1 | 1992 | 791 | 0.010 |
Why?
|
| Leukapheresis | 1 | 2003 | 8 | 0.010 |
Why?
|
| Aortic Valve Stenosis | 1 | 2005 | 177 | 0.010 |
Why?
|
| Echocardiography | 1 | 2006 | 515 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2004 | 308 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 2006 | 481 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2007 | 498 | 0.010 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2003 | 37 | 0.010 |
Why?
|
| Nasal Cavity | 1 | 2003 | 62 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2004 | 230 | 0.010 |
Why?
|
| Hydroxyproline | 1 | 2002 | 33 | 0.010 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2002 | 32 | 0.010 |
Why?
|
| Mice, Mutant Strains | 2 | 1995 | 166 | 0.010 |
Why?
|
| Fascia | 2 | 1994 | 17 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 2002 | 149 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 2002 | 69 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 370 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2003 | 226 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2003 | 241 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 2324 | 0.010 |
Why?
|
| Tissue Adhesions | 2 | 1993 | 21 | 0.010 |
Why?
|
| Cell Survival | 1 | 2004 | 901 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2004 | 1200 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2003 | 266 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2003 | 791 | 0.010 |
Why?
|
| RNA | 1 | 2002 | 171 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2002 | 489 | 0.010 |
Why?
|
| Reference Values | 2 | 1993 | 579 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 3 | 1994 | 2791 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 1990 | 1242 | 0.010 |
Why?
|
| Gene Expression | 1 | 2003 | 770 | 0.010 |
Why?
|
| Myocardium | 1 | 2005 | 1204 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1999 | 67 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2006 | 1615 | 0.010 |
Why?
|
| Vasoconstrictor Agents | 1 | 1999 | 107 | 0.010 |
Why?
|
| Tissue Kallikreins | 1 | 1999 | 106 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 1997 | 31 | 0.010 |
Why?
|
| Keratins | 1 | 1997 | 48 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 710 | 0.010 |
Why?
|
| Vimentin | 1 | 1997 | 47 | 0.010 |
Why?
|
| Inflammation | 1 | 2003 | 1030 | 0.010 |
Why?
|
| S100 Proteins | 1 | 1997 | 42 | 0.010 |
Why?
|
| Microscopy, Polarization | 1 | 1996 | 7 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 1997 | 191 | 0.010 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 1996 | 22 | 0.010 |
Why?
|
| Molecular Probes | 1 | 1996 | 27 | 0.010 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1996 | 27 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1996 | 189 | 0.010 |
Why?
|
| Mediastinum | 1 | 1996 | 39 | 0.010 |
Why?
|
| Mucous Membrane | 1 | 1996 | 66 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 1996 | 110 | 0.010 |
Why?
|
| Viral Proteins | 1 | 1997 | 150 | 0.010 |
Why?
|
| Lymphocyte Subsets | 1 | 1996 | 16 | 0.010 |
Why?
|
| Immunity, Mucosal | 1 | 1996 | 19 | 0.010 |
Why?
|
| Foreign Bodies | 1 | 1996 | 58 | 0.010 |
Why?
|
| Models, Immunological | 1 | 1996 | 25 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1996 | 358 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1996 | 282 | 0.010 |
Why?
|
| Nasal Mucosa | 1 | 1996 | 68 | 0.010 |
Why?
|
| Prosthesis Failure | 1 | 1996 | 130 | 0.010 |
Why?
|
| Time Factors | 2 | 1997 | 4655 | 0.010 |
Why?
|
| Complement Hemolytic Activity Assay | 1 | 1995 | 4 | 0.010 |
Why?
|
| Mitogens | 1 | 1995 | 45 | 0.010 |
Why?
|
| Polysaccharides, Bacterial | 1 | 1995 | 31 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1996 | 492 | 0.010 |
Why?
|
| Splenectomy | 1 | 1995 | 40 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1996 | 532 | 0.010 |
Why?
|
| Streptococcus pneumoniae | 1 | 1995 | 32 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 1996 | 258 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1995 | 93 | 0.010 |
Why?
|
| Base Sequence | 1 | 1996 | 1015 | 0.010 |
Why?
|
| Quinolinic Acid | 1 | 1994 | 11 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 1996 | 562 | 0.010 |
Why?
|
| Intermediate Filaments | 1 | 1993 | 6 | 0.010 |
Why?
|
| Muscles | 1 | 1994 | 158 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1996 | 1447 | 0.010 |
Why?
|
| Macrophage Activation | 1 | 1993 | 75 | 0.010 |
Why?
|
| Injections | 1 | 1993 | 119 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 1993 | 47 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 1995 | 329 | 0.010 |
Why?
|
| Autoantibodies | 1 | 1995 | 434 | 0.010 |
Why?
|
| Vasculitis | 1 | 1992 | 33 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1992 | 228 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1997 | 3187 | 0.010 |
Why?
|
| Narcotics | 1 | 1990 | 65 | 0.010 |
Why?
|
| Methods | 1 | 1989 | 156 | 0.010 |
Why?
|
| Pulmonary Edema | 1 | 1989 | 37 | 0.010 |
Why?
|
| Permeability | 1 | 1989 | 131 | 0.010 |
Why?
|
| Capillaries | 1 | 1989 | 105 | 0.010 |
Why?
|
| Spleen | 1 | 1989 | 301 | 0.010 |
Why?
|
| Cannabis | 1 | 1990 | 115 | 0.000 |
Why?
|
| Graft Survival | 1 | 1989 | 465 | 0.000 |
Why?
|
| Cocaine | 1 | 1990 | 555 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1989 | 3259 | 0.000 |
Why?
|